Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep 9;119(36):e2207273119.
doi: 10.1073/pnas.2207273119. Epub 2022 Aug 15.

Novel genes/loci validate the small effect size of ERBB2 in patients with myasthenia gravis

Zijun Zhu  1 , Xinyu Chen  1 , Chao Wang  1 , Liang Cheng  1   2
Affiliations
Comment

Novel genes/loci validate the small effect size of ERBB2 in patients with myasthenia gravis

Zijun Zhu et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Figures

Fig. 1.
Fig. 1.
Genomic genes identified by SMR. (A) Schematic diagram of the MR method. (B) SMR locus plot for ERBB2. (C) SMR effect plot for ERBB2.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Chia R., et al. ; International Myasthenia Gravis Genomics Consortium, Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: A genome-wide association study. Proc. Natl. Acad. Sci. U.S.A. 119, e2108672119 (2022). - PMC - PubMed
    1. Davey Smith G., Hemani G., Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89–R98 (2014). - PMC - PubMed
    1. Emdin C. A., Khera A. V., Kathiresan S., Mendelian randomization. JAMA 318, 1925–1926 (2017). - PubMed
    1. Pairo-Castineira E., et al. ; GenOMICC Investigators; ISARIC4C Investigators; COVID-19 Human Genetics Initiative; 23andMe Investigators; BRACOVID Investigators; Gen-COVID Investigators, Genetic mechanisms of critical illness in COVID-19. Nature 591, 92–98 (2021). - PubMed
    1. Chohan H., et al. , Type 2 diabetes as a determinant of Parkinson’s disease risk and progression. Mov. Disord. 36, 1420–1429 (2021). - PMC - PubMed